The only way to do good work is to do it with passion.
The plant will cover an area of 40,000 square meters, including 10,000 square meters for greenhouses, as the vaccines are made from plants. Initially estimated at $245 million, the construction cost has recently been revised upward. Revenco is responsible for carrying out the development work.
Medicago plans to produce 40 to 50 million doses of quadrivalent seasonal flu vaccines annually. In the event of a pandemic, the plant will be able to produce a vaccine more quickly, in 5 to 6 weeks, compared to 5 to 6 months for traditional technologies.